Literature DB >> 16724899

Antegrade endopyelotomy for treatment of ureteropelvic junction obstruction in transplanted kidneys.

Martin Schumacher1, U E Studer, H Danuser.   

Abstract

BACKGROUND AND
PURPOSE: Little is known about the incidence and treatment of ureteropelvic junction (UPJ) obstruction of renal grafts. We report on three cases treated by endopyelotomy. PATIENTS AND METHODS: Graft function declined in three patients 98, 135, and 144 days after kidney transplantation. Acute rejection was excluded by renal biopsy. Ultrasonography revealed a dilated collecting system, and a percutaneous nephrostomy tube was placed. An antegrade nephrostogram showed UPJ obstruction. Percutaneous antegrade endopyelotomy was performed with the cold-knife technique, and the area was stented for 6 weeks using a 14F/8.2F Smith endopyelotomy stent.
RESULTS: No intraoperative or postoperative complications occurred. The endopyelotomies were successful, and the creatinine clearances returned to normal.
CONCLUSION: Antegrade endopyelotomy in patients with UPJ obstruction of a renal graft is feasible and effective. Normal kidney function was restored after correction of the obstruction.

Entities:  

Mesh:

Year:  2006        PMID: 16724899     DOI: 10.1089/end.2006.20.305

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  3 in total

1.  Urological Complications Associated With Pyeloureterostomy Without Ipsilateral Nephrectomy in Renal Transplant Recipients.

Authors:  Hernani M Neto; Helio Tedesco Silva Junior; José M Pestana; Renato D Foresto; Wilson F Aguiar
Journal:  Transpl Int       Date:  2022-01-18       Impact factor: 3.782

2.  Equivocal pelvi-ureteric junction obstruction manifesting in a renal transplant recipient.

Authors:  Vivek Venkatramani; Rajiv P Mukha; Nitin S Kekre
Journal:  Indian J Urol       Date:  2012-07

3.  The outcome of kidney transplant from living donors with pelvi-ureteric junction dysfunction.

Authors:  Miroslav Tisljar; Hatem Ali; Charlie Gledhill-Flynn; Mila Garreus; Arvind Ponnusamy; Aimun Ahmed
Journal:  Int Urol Nephrol       Date:  2020-06-10       Impact factor: 2.370

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.